TCM Biotech International Corp. (4169.TWO)
- Previous Close
56.50 - Open
56.50 - Bid 54.80 x --
- Ask 55.80 x --
- Day's Range
54.10 - 56.50 - 52 Week Range
43.65 - 63.60 - Volume
32,790 - Avg. Volume
91,310 - Market Cap (intraday)
3.295B - Beta (5Y Monthly) -0.26
- PE Ratio (TTM)
155.00 - EPS (TTM)
0.36 - Earnings Date --
- Forward Dividend & Yield 0.29 (0.51%)
- Ex-Dividend Date Aug 28, 2024
- 1y Target Est
113.00
TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company's products include osteoarthritis treatment products, osteoporosis treatment preparations, iron supplement, urinary system treatment products, expectorants/mucolytic agents, anti-hypertensive preparations, and anti-diabetic preparations, anti-adhesion systems, pellefeel wound care systems, Philips non-invasive ventilators, and others, as well as medical devices and functional foods. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
www.tcmbio.comRecent News: 4169.TWO
View MorePerformance Overview: 4169.TWO
Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4169.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4169.TWO
View MoreValuation Measures
Market Cap
3.33B
Enterprise Value
2.85B
Trailing P/E
156.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.94
Price/Book (mrq)
3.14
Enterprise Value/Revenue
4.27
Enterprise Value/EBITDA
56.41
Financial Highlights
Profitability and Income Statement
Profit Margin
3.15%
Return on Assets (ttm)
0.53%
Return on Equity (ttm)
1.99%
Revenue (ttm)
666.53M
Net Income Avi to Common (ttm)
21.01M
Diluted EPS (ttm)
0.36
Balance Sheet and Cash Flow
Total Cash (mrq)
532.98M
Total Debt/Equity (mrq)
4.10%
Levered Free Cash Flow (ttm)
146.85M